Cargando…

Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer

Lung cancer treatment has rapidly changed in the last few years thanks to novel insights into cancer biology. Several biomarkers and signaling pathways have been recognized as conceivable targets for treatment, and among them is the mesenchymal–epithelial transition/hepatocyte growth factor (c-MET/H...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Arcangelo, Manolo, Cappuzzo, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593708/ https://www.ncbi.nlm.nih.gov/pubmed/23493885 http://dx.doi.org/10.2147/BTT.S28908

Ejemplares similares

K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value
por: D'Arcangelo, Manolo, et al.
Publicado: (2012)

Clinical and comparative utility of afatinib in non-small cell lung cancer
por: D’Arcangelo, Manolo, et al.
Publicado: (2014)

The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects
por: Bravaccini, Sara, et al.
Publicado: (2021)

Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC)
por: Vecchiarelli, Silvia, et al.
Publicado: (2018)

Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer
por: Stasi, Irene, et al.
Publicado: (2014)

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer
por: D’Arcangelo, Manolo, et al.
Publicado: (2019)

Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study
por: D’Arcangelo, Manolo, et al.
Publicado: (2015)

Treating EGFR mutation resistance in non-small cell lung cancer – role of osimertinib
por: Mazza, Valentina, et al.
Publicado: (2017)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer
por: Perez, Kimberly, et al.
Publicado: (2023)

Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
por: Stasi, Irene, et al.
Publicado: (2014)

Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma
por: Patnaik, A, et al.
Publicado: (2014)

KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges
por: Ceddia, Serena, et al.
Publicado: (2022)

Physical Exercise and Health: A Focus on Its Protective Role in Neurodegenerative Diseases
por: Bonanni, Roberto, et al.
Publicado: (2022)

Gemcitabine for the treatment of advanced nonsmall cell lung cancer
por: Toschi, Luca, et al.
Publicado: (2009)

Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC
por: Tan, Eng‐Huat, et al.
Publicado: (2018)

Patient-derived cell line, xenograft and organoid models in lung cancer therapy
por: Huo, Ku-Geng, et al.
Publicado: (2020)

Treatment of postherpetic neuralgia: focus on pregabalin
por: Cappuzzo, Kimberly A
Publicado: (2009)

The Role of p16(INK4a) Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer
por: D’Arcangelo, Daniela, et al.
Publicado: (2017)

Perioperative outcomes of robotic lobectomy for early-stage non-small cell lung cancer in elderly patients
por: Gallina, Filippo Tommaso, et al.
Publicado: (2022)

ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases
por: Cappuzzo, F, et al.
Publicado: (2003)

How selecting best upfront therapy for metastatic disease?—Focus on ROS1-rearranged disease
por: Landi, Lorenza, et al.
Publicado: (2020)

Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials
por: Li, Lee X, et al.
Publicado: (2023)

Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
por: Melosky, Barbara, et al.
Publicado: (2021)

Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer
por: Gallina, Filippo Tommaso, et al.
Publicado: (2022)

Rituximab treatment in a case of antisynthetase syndrome with severe interstitial lung disease and acute respiratory failure
por: Zappa, Maria Cristina, et al.
Publicado: (2011)

Potential Prognostic Role of SPARC Methylation in Non-Small-Cell Lung Cancer
por: Fabrizio, Federico Pio, et al.
Publicado: (2020)

Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics
por: Guo, Matthew Z, et al.
Publicado: (2021)

Letter to the Editor: “Ion Channels in Brain Metastasis”—Ion Channels in Cancer Set up and Metastatic Progression
por: D’Arcangelo, Daniela, et al.
Publicado: (2017)

New Insights into Reelin-Mediated Signaling Pathways
por: Lee, Gum Hwa, et al.
Publicado: (2016)

EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer
por: Varella-Garcia, M, et al.
Publicado: (2009)

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
por: Landi, Lorenza, et al.
Publicado: (2019)

The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer
por: Bronte, Giuseppe, et al.
Publicado: (2021)

Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents
por: Vergnenègre, A, et al.
Publicado: (2013)

Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib
por: Zugazagoitia, Jon, et al.
Publicado: (2017)

Potential role of immunotherapy in advanced non-small-cell lung cancer
por: de Mello, Ramon Andrade, et al.
Publicado: (2016)

The Potential Role of Cathepsin K in Non-Small Cell Lung Cancer
por: Yang, Hui, et al.
Publicado: (2020)

Safe and Ultraconservative Rehabilitation of Worn Teeth Patients: How Sectional Clear Aligners May Enhance the Prosthetic Treatment Plan
por: D'Arcangelo, Camillo, et al.
Publicado: (2022)

Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative Review
por: Gallina, Filippo Tommaso, et al.
Publicado: (2022)

Editorial: Reelin-Related Neurological Disorders and Animal Models
por: D'Arcangelo, Gabriella, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_us1t9ht45hc4acqpgk96kosae4